Norman E. Sharpless
Impact in
- Aging top 0.05%
- Genetics, Aging, and Longevity in Model Organisms
- Physiology top 0.1%
- Telomeres, Telomerase, and Senescence
Papers in
- Oncology 52
- Cancer-related Molecular Pathways 32
- Physiology 54
- Telomeres, Telomerase, and Senescence 52
- Co-authors
- William R. Jeck (11 shared papers)Ronald Anthony DePinho (26 shared papers)Shenghui He (6 shared papers)Christin Elizabeth Burd (10 shared papers)Janakiraman Krishnamurthy (20 shared papers)Jessica A. Sorrentino (8 shared papers)Matthew R. Ramsey (7 shared papers)Chad Torrice (16 shared papers)
- Journals
- Journal of Clinical Investigation (17 papers)Nature (10 papers)Cancer Cell (10 papers)Cell (10 papers)PLoS ONE (7 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Norman E. Sharpless
181 papers receiving 37k citations
Norman E. Sharpless's Hit Papers
Peers
Comparison fields: 5 of 176
- Aging 1.6k
- Physiology 7.5k
- Oncology 5.9k
- Molecular Biology 14k
- Cancer Research 2.7k
Countries citing papers authored by Norman E. Sharpless
This map shows the geographic impact of Norman E. Sharpless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman E. Sharpless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman E. Sharpless more than expected).
Fields of papers citing papers by Norman E. Sharpless
This network shows the impact of papers produced by Norman E. Sharpless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman E. Sharpless. The network helps show where Norman E. Sharpless may publish in the future.
Co-authors
The 25 scholars most cited alongside Norman E. Sharpless, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNAs are abundant, conserved, and associated with ALU repeats Hit paper breakdown → | 2012 | 3626 |
| 2 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2540 |
| 3 | Detecting and characterizing circular RNAs Hit paper breakdown → | 2014 | 2168 |
| 4 | Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice Hit paper breakdown → | 2015 | 1512 |
| 5 | Senescence in Health and Disease Hit paper breakdown → | 2017 | 1438 |
| 6 | Ink4a/Arf expression is a biomarker of aging Hit paper breakdown → | 2004 | 1246 |
| 7 | Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse Hit paper breakdown → | 2016 | 1100 |
| 8 | Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a Hit paper breakdown → | 2006 | 918 |
| 9 | Forging a signature of in vivo senescence Hit paper breakdown → | 2015 | 914 |
| 10 | LKB1 modulates lung cancer differentiation and metastasis Hit paper breakdown → | 2007 | 878 |
| 11 | p16INK4a induces an age-dependent decline in islet regenerative potential Hit paper breakdown → | 2006 | 852 |
| 12 | The Regulation of INK4/ARF in Cancer and Aging Hit paper breakdown → | 2006 | 829 |
| 13 | 2006 | 803 | |
| 14 | Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk Hit paper breakdown → | 2010 | 764 |
| 15 | 2007 | 710 | |
| 16 | 2001 | 690 | |
| 17 | CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Hit paper breakdown → | 2017 | 623 |
| 18 | Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer Hit paper breakdown → | 2012 | 618 |
| 19 | 2002 | 544 | |
| 20 | The mighty mouse: genetically engineered mouse models in cancer drug development Hit paper breakdown → | 2006 | 542 |
About Norman E. Sharpless
Norman E. Sharpless is a scholar working on Oncology, Physiology, Aging, Cancer Research and Molecular Biology, having authored 190 papers that have together received 37.7k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (52 papers), Cancer-related Molecular Pathways (32 papers), Melanoma and MAPK Pathways (21 papers), Genetics, Aging, and Longevity in Model Organisms (19 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (8 papers), Esophageal Cancer Research and Treatment (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). The work is most often cited by research in Aging (1.6k citations), Physiology (7.5k citations), Oncology (5.9k citations), Molecular Biology (14k citations) and Cancer Research (2.7k citations). Norman E. Sharpless has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include William R. Jeck, Ronald Anthony DePinho, Shenghui He, Christin Elizabeth Burd, Janakiraman Krishnamurthy, Jessica A. Sorrentino, Matthew R. Ramsey, Chad Torrice, Charles J. Sherr and William F. Marzluff. Their work appears in journals such as Journal of Clinical Investigation, Nature, Cancer Cell, Cell and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.